Pablo Miguel
Barreiro Garcia
Hospital Juan Ramón Jiménez
Huelva, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Juan Ramón Jiménez (5)
2014
-
Causas que justifican el cambio del tratamiento antirretroviral en personas con infección por el VIH en España (años 2010-2011). Estudio SWITCH AUDIT
Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 93-97
2013
-
Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection
AIDS, Vol. 27, Núm. 17, pp. 2715-2724
2008
-
Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients
Journal of Hepatology, Vol. 49, Núm. 6, pp. 916-922
-
Efficacy of pegylated interferon plus ribavirin treatment in HIV/ hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1365-1373
-
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
Antiviral Therapy, Vol. 13, Núm. 3, pp. 429-437